The Effect Of Erythropoietin In The Treatment Of Acute Spinal Cord Injury

Zhaohui Cheng,Tiao Lin,Weishan Chen,Weigang Wu,Shigui Yan
2016-01-01
Abstract:Objectives: The aim of this study was to evaluate the recovery of motor and sensory function in patients with acute spinal cord injury (ASCI) after recombinant human erythropoietin (EPO) treatment. The safety and efficacy of EPO for ASCI was discussed as well. Methods: The clinical data of 60 ASCI cases were analyzed in a retrospective manner, in which EPO-treated therapy group (n=30) and the EPO-untreated group (n=30) were included. The neurological function of each patient at admission, twelve and twenty- fourth months were reviewed. The adverse events were recorded as well. Results: All of the 60 patients were followed up for 2 similar to 3 years (average 2.4 years) after treatment. The follow-up of both groups showed that the patients in the therapy group had a better improvement in the AIS and ASIA motor score and more sensation of touch than the control group (P<0.05). No statistically significant difference regarding the red blood cell count and hemoglobin (Hb) concentration between therapy group and control group was found (P>0.05). Conclusion: EPO is a safe and effective drug for treating ASCI. Early application of EPO can promote the recovery of the motor and sensory function in patients with ASCI.
What problem does this paper attempt to address?